When to order a Fractional Excretion of Sodium (FENa) in a patient with acute kidney injury (AKI) of uncertain cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Order Fractional Excretion of Sodium (FENa) in AKI of Uncertain Cause

FENa should be ordered in patients with acute kidney injury of uncertain etiology, particularly when distinguishing between prerenal and intrinsic renal causes would alter management decisions, and ideally before diuretic administration. 1, 2

Indications for FENa Testing

  • Primary indications:

    • New-onset oliguric AKI without clear etiology
    • Need to differentiate between prerenal azotemia and acute tubular necrosis (ATN)
    • AKI with conflicting clinical features suggesting both volume depletion and intrinsic renal injury
  • Optimal timing:

    • Before administration of diuretics when possible
    • Early in the course of AKI before multiple etiologies develop
    • When volume status assessment is clinically challenging

Interpretation of FENa Results

  • FENa < 1%: Typically indicates prerenal causes (volume depletion, decreased effective arterial blood volume) 1, 3
  • FENa > 1%: Suggests intrinsic renal causes such as ATN 1, 3
  • FENa > 3%: Strongly indicative of ATN 3

Clinical Scenarios Where FENa is Most Useful

  • Oliguric patients without CKD or diuretic use: FENa has highest diagnostic accuracy with sensitivity of 95% and specificity of 91% 2
  • Volume status uncertainty: When physical examination findings are equivocal
  • Monitoring recovery: A decreasing FENa in a patient with established ATN may indicate development of volume depletion that could delay recovery 4

Limitations and Caveats

  • Reduced accuracy in specific populations:

    • Patients on diuretics: Sensitivity drops to 80%, specificity to 54% 2
    • Patients with CKD: Diagnostic performance is diminished 2
    • Patients with cirrhosis: FENa has poor specificity (14%) for prerenal causes despite high sensitivity 1, 5
  • Alternative tests when FENa is less reliable:

    • Fractional Excretion of Urea (FEUrea): More reliable in patients on diuretics 6
      • FEUrea < 35% suggests prerenal causes even in patients on diuretics 6
      • In cirrhosis, FEUrea < 28.16% has 75% sensitivity and 83% specificity for hepatorenal syndrome 1
    • Urinary sodium:creatinine ratio: Easier to measure and correlates with FENa 1

Algorithm for FENa Testing in AKI

  1. Confirm AKI diagnosis using KDIGO criteria:

    • Increase in serum creatinine by ≥0.3 mg/dL within 48h, or
    • Increase in serum creatinine to ≥1.5 times baseline within 7 days, or
    • Urine volume <0.5 mL/kg/h for 6h 7
  2. Assess if etiology is uncertain after initial evaluation

  3. Order FENa if:

    • Patient is not on diuretics AND
    • Patient does not have advanced CKD AND
    • Distinguishing prerenal from intrinsic causes would change management
  4. Consider FEUrea instead of FENa if:

    • Patient is on diuretics OR
    • Patient has cirrhosis
  5. Interpret results in clinical context and adjust management accordingly

Remember that while FENa is a valuable diagnostic tool, its interpretation must be integrated with other clinical and laboratory findings for optimal management of AKI.

References

Guideline

Acute Kidney Injury Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fractional excretion of sodium as a guide to volume depletion during recovery from acute renal failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.